Multiple therapeutic targets in rare cholestatic liver diseases: time to redefine treatment strategies

Alessio Gerussi, Daphne-D Amato, Laura Cristoferi, Sarah Elizabeth O Donnell, Marco Carbone, Pietro Invernizzi
2019 Annals of Hepatology  
Primary biliary cholangitis and primary sclerosing cholangitis are rare diseases affecting the bile ducts and the liver. The limited knowledge of their pathogenesis leads to limited therapeutic options. Nevertheless, the landscape of novel therapies for these cholangiopathies is now rapidly changing, providing new treatment opportunities for patients and clinicians involved in their care. The aim of this review is to summarize the evidence of novel molecules under investigation for primary
more » ... ry cholangitis and primary sclerosing cholangitis and to discuss how they can potentially change current treatment paradigms.
doi:10.1016/j.aohep.2019.09.009 pmid:31771820 fatcat:ipbsndxjgbfzdpioeze3naj6hq